Mitochondrial Ca2+ and neurodegeneration

Cell Calcium

Volumn 52, Issue 1, 2012, Pages 73-85

  Calì, Tito ^a   Ottolini, Denis ^a   Brini, Marisa ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Calcium signaling; Mitochondria; Mitochondrial quality control; Neurodegenerative diseases; Neurons

Indexed keywords

CALCIUM ION; CARRIER PROTEINS AND BINDING PROTEINS; DJ 1 PROTEIN; GUANOSINE TRIPHOSPHATASE; MITOCHONDRIAL CALCIUM UNIPORTER PROTEIN; MITOCHONDRIAL CALCIUM UPTAKE 1 PROTEIN; MITOCHONDRIAL PROTEIN; MITOFUSIN 1; MITOFUSIN 2; OPTIC ATROPHY 1 PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL ACTIVITY; CELL FUSION; CELL MIGRATION; CELL STRESS; HUMAN; HUNTINGTON CHOREA; INTRACELLULAR SIGNALING; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MITOPHAGY; NERVE DEGENERATION; NERVE FUNCTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SODIUM CALCIUM EXCHANGE;

EID: 84863225093     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2012.04.015     Document Type: Article

References (177)

1. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nature Reviews Molecular Cell Biology 2003, 4:517-529.
2. Berridge M.J. Inositol trisphosphate and calcium signalling mechanisms. Biochimica et Biophysica Acta 2009, 1793:933-940.
3. Brini M., Carafoli E. Calcium pumps in health and disease. Physiological Reviews 2009, 89:1341-1378.
4. Mammucari C., Patron M., Granatiero V., Rizzuto R. Molecules and roles of mitochondrial calcium signaling. Biofactors 2011, 37:219-227.
5. 2+ as a key regulator of mitochondrial activities. Advances in mitochondrial medicine. Advances in Experimental Medicine and Biology Series 2012, 942:53-73.
6. Schon E.A., Przedborski S. Mitochondria: the next (neurode)generation. Neuron 2011, 70:1033-1053.
7. Drago I., Pizzo P., Pozzan T. After half a century mitochondrial calcium in- and efflux machineries reveal themselves. EMBO Journal 2011, 30:4119-4125.
8. De Stefani D., Raffaello A., Teardo E., Szabo I., Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 2011, 476:336-340.
9. Baughman J.M., Perocchi F., Girgis H.S., Plovanich M., Belcher-Timme C.A., et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 2011, 476:341-345.
10. Perocchi F., Gohil V.M., Girgis H.S., Bao X.R., McCombs J.E., et al. MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake. Nature 2010, 467:291-296.
11. 2+ exchange. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:436-441.
12. 2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 1993, 262:744-747.
13. 2+ responses. Science 1998, 280:1763-1766.
14. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
15. Hoth M., Fanger C.M., Lewis R.S. Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. Journal of Cell Biology 1997, 137:633-648.
16. Pizzo P., Lissandron V., Capitanio P., Pozzan T. Ca(2+) signalling in the Golgi apparatus. Cell Calcium 2011, 50:184-192.
17. Ricchelli F., Sileikyte J., Bernardi P. Shedding light on the mitochondrial permeability transition. Biochimica et Biophysica Acta 2011, 1807:482-490.
18. 2+ channels. Journal of Cell Biology 2006, 175:901-911.
19. 2+-dependent regulation of mitochondrial dynamics by the Miro-Milton complex. International Journal of Biochemistry and Cell Biology 2009, 41:1972-1976.
20. MacAskill A.F., Kittler J.T. Control of mitochondrial transport and localization in neurons. Trends in Cell Biology 2010, 20:102-112.
21. 2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:20728-20733.
22. 2+]i. Journal of Neuroscience 1994, 14:4007-4024.
23. Bezprozvanny I., Watras J., Ehrlich B.E. Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 1991, 351:751-754.
24. 2+ channels. Molecular Cell 2010, 38:280-290.
25. 2+ uptake. EMBO Journal 2002, 21:6744-6754.
26. Quintana A., Schwarz E.C., Schwindling C., Lipp P., Kaestner L., et al. Sustained activity of calcium release-activated calcium channels requires translocation of mitochondria to the plasma membrane. Journal of Biological Chemistry 2006, 281:40302-40309.
27. Walsh C., Barrow S., Voronina S., Chvanov M., Petersen O.H., et al. Modulation of calcium signalling by mitochondria. Biochimica et Biophysica Acta 2009, 1787:1374-1382.
28. Deisseroth K., Mermelstein P.G., Xia H., Tsien R.W. Signaling from synapse to nucleus: the logic behind the mechanisms. Current Opinion in Neurobiology 2003, 13:354-365.
29. 2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. Journal of Neuroscience 2009, 29:12101-12114.
30. Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Current Opinion in Cell Biology 2010, 22:124-131.
31. Twig G., Elorza A., Molina A.J., Mohamed H., Wikstrom J.D., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. The EMBO Journal 2008, 27:433-446.
32. 2+ homeostasis in the endoplasmic reticulum. Cell Death and Differentiation 2006, 13:1409-1418.
33. Vicencio J.M., Ortiz C., Criollo A., Jones A.W., Kepp O., et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death and Differentiation 2009, 16:1006-1017.
34. 2+ transfer to mitochondria. Cell 2010, 142:270-283.
35. Sakaki K., Wu J., Kaufman R.J. Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum. The Journal of Biological Chemistry 2008, 283:15370-15380.
36. Decuypere J.P., Bultynck G., Parys J.B. A dual role for Ca(2+) in autophagy regulation. Cell Calcium 2011, 50:242-250.
37. Imai Y., Lu B. Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorder. Current Opinion in Neurobiology 2011, 21:935-941.
38. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. Journal of Cell Biology 2010, 191:1367-1380.
39. Gegg M.E., Cooper J.M., Chau K.Y., Rojo M., Schapira A.H., et al. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Human Molecular Genetics 2010, 19:4861-4870.
40. Chan N.C., Salazar A.M., Pham A.H., Sweredoski M.J., Kolawa N.J., et al. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Human Molecular Genetics 2011, 20:1726-1737.
41. Wang H., Song P., Du L., Tian W., Yue W., et al. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease. Journal of Biological Chemistry 2011, 286:11649-11658.
42. Geisler S., Holmstrom K.M., Skujat D., Fiesel F.C., Rothfuss O.C., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology 2010, 12:119-131.
43. Chen D., Gao F., Li B., Wang H., Xu Y., et al. Parkin mono-ubiquitinates Bcl-2 and regulates autophagy. Journal of Biological Chemistry 2010, 285:38214-38223.
44. Wang X., Winter D., Ashrafi G., Schlehe J., Wong Y.L., et al. PINK1 and Parkin Target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147:893-906.
45. Kornmann B., Osman C., Walter P. The conserved GTPase Gem1 regulates endoplasmic reticulum-mitochondria connections. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14151-14156.
46. White C., Li C., Yang J., Petrenko N.B., Madesh M., et al. The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nature Cell Biology 2005, 7:1021-1028.
47. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
48. 2+ signaling, which do not depend on their putative pore-forming region. Journal of Biological Chemistry 2004, 279:54581-54589.
49. 2+: a control point for apoptosis. Science 2003, 300:135-139.
50. Pacher P., Hajnoczky G. Propagation of the apoptotic signal by mitochondrial waves. EMBO Journal 2001, 20:4107-4121.
51. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nature Medicine 2000, 6:513-519.
52. 2+ transfer in the control of apoptosis. Oncogene 2008, 27:6407-6418.
53. Jahani-Asl A., Cheung E.C., Neuspiel M., MacLaurin J.G., Fortin A., et al. Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death. The Journal of Biological Chemistry 2007, 282:23788-23798.
54. Barsoum M.J., Yuan H., Gerencser A.A., Liot G., Kushnareva Y., et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. The EMBO Journal 2006, 25:3900-3911.
55. Jahani-Asl A., Germain M., Slack R.S. Mitochondria: joining forces to thwart cell death. Biochimica et Biophysica Acta 2010, 1802:162-166.
56. Lee H.C., Wei Y.H. Mitochondrial role in life and death of the cell. Journal of Biomedical Science 2000, 7:2-15.
57. Chang D.T., Rintoul G.L., Pandipati S., Reynolds IJ Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiology of Disease 2006, 22:388-400.
58. Forte M., Gold B.G., Marracci G., Chaudhary P., Basso E., et al. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:7558-7563.
59. Weihofen A., Thomas K.J., Ostaszewski B.L., Cookson M.R., Selkoe D.J. Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry 2009, 48:2045-2052.
60. Mattson M.P., Gleichmann M., Cheng A. Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
61. Rintoul G.L., Reynolds I.J. Mitochondrial trafficking and morphology in neuronal injury. Biochimica et Biophysica Acta 2010, 1802:143-150.
62. Shankar G.M., Walsh D.M. Alzheimer's disease: synaptic dysfunction and Abeta. Molecular Neurodegeneration 2009, 4:48.
63. Iijima-Ando K., Hearn S.A., Shenton C., Gatt A., Zhao L., et al. Mitochondrial mislocalization underlies Abeta42-induced neuronal dysfunction in a Drosophila model of Alzheimer's disease. PLoS One 2009, 4:e8310.
64. Zhao X.L., Wang W.A., Tan J.X., Huang J.K., Zhang X., et al. Expression of beta-amyloid induced age-dependent presynaptic and axonal changes in Drosophila. Journal of Neuroscience 2010, 30:1512-1522.
65. Wang X., Su B., Lee H.G., Li X., Perry G., et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. Journal of Neuroscience 2009, 29:9090-9103.
66. Youle R.J., Narendra D.P. Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology 2011, 12:9-14.
67. Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway: a mitochondrial quality control system?. Journal of Bioenergetics and Biomembranes 2009, 41:499-503.
68. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nature Neuroscience 2002, 5:731-736.
69. Lim D., Fedrizzi L., Tartari M., Zuccato C., Cattaneo E., et al. Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. Journal of Biological Chemistry 2008, 283:5780-5789.
70. Faes L., Callewaert G. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. Journal of Bioenergetics and Biomembranes 2011, 43:587-592.
71. Goedert M., Spillantini M.G. A century of Alzheimer's disease. Science 2006, 314:777-781.
72. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nature Reviews Neuroscience 2007, 8:499-509.
73. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
74. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
75. Demuro A., Parker I., Stutzmann G.E. Calcium signaling and amyloid toxicity in Alzheimer disease. The Journal of Biological Chemistry 2010, 285:12463-12468.
76. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489.
77. Tolar M., Keller J.N., Chan S., Mattson M.P., Marques M.A., et al. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1999, 19:7100-7110.
78. Boada M., Antunez C., Lopez-Arrieta J., Galan J.J., Moron F.J., et al. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. Journal of Alzheimer's Disease 2010, 20:247-251.
79. 2+ release from intracellular stores. Neurobiology of Disease 2004, 15:269-278.
80. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., et al. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. The Journal of Biological Chemistry 2005, 280:17294-17300.
81. Khachaturian Z.S. Calcium hypothesis of Alzheimer's disease and brain aging. Annals of the New York Academy of Sciences 1994, 747:1-11.
82. Ferreiro E., Oliveira C.R., Pereira C.M. The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiology of Disease 2008, 30:331-342.
83. 2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One 2008, 3:e2718.
84. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., et al. Mitochondrial abnormalities in Alzheimer's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:3017-3023.
85. Wang X., Su B., Lee H.G., Li X., Perry G., et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29:9090-9103.
86. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
87. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19318-19323.
88. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., et al. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:4499-4508.
89. Brustovetsky N., Dubinsky J.M., Antonsson B., Jemmerson R. Two pathways for tBID-induced cytochrome c release from rat brain mitochondria: BAK- versus BAX-dependence. Journal of Neurochemistry 2003, 84:196-207.
90. Jiang D., Sullivan P.G., Sensi S.L., Steward O., Weiss J.H. Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. The Journal of Biological Chemistry 2001, 276:47524-47529.
91. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., et al. Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2005, 19:2040-2041.
92. Du H., Guo L., Fang F., Chen D., Sosunov A.A., et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nature Medicine 2008, 14:1097-1105.
93. Annaert W.G., Levesque L., Craessaerts K., Dierinck I., Snellings G., et al. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. Journal of Cell Biology 1999, 147:277-294.
94. Ankarcrona M., Hultenby K. Presenilin-1 is located in rat mitochondria. Biochemical and Biophysical Research Communications 2002, 295:766-770.
95. Hansson C.A., Frykman S., Farmery M.R., Tjernberg L.O., Nilsberth C., et al. Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. The Journal of Biological Chemistry 2004, 279:51654-51660.
96. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006, 126:981-993.
97. 2+ leak function of presenilin 1. Journal of Clinical Investigation 2007, 117:1230-1239.
98. 2+ entry is associated with the familial Alzheimer's disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiology of Disease 2005, 18:638-648.
99. Zatti G., Burgo A., Giacomello M., Barbiero L., Ghidoni R., et al. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 2006, 39:539-550.
100. 2+ entry into HEK293 cells. Cellular Signalling 2005, 17:437-445.
101. 2+ content in presenilin double knock-out cells. Cell Calcium 2006, 40:41-51.
102. 2+ leak channels. Journal of Biological Chemistry 2012, 287:10933-10934.
103. 2+ uptake. Journal of Cellular and Molecular Medicine 2009, 13:3358-3369.
104. 2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating. Neuron 2008, 58:871-883.
105. Cheung K.H., Mei L., Mak D.O., Hayashi I., Iwatsubo T., et al. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Science Signaling 2010, 3:ra22.
106. Area-Gomez E., de Groof A.J., Boldogh I., Bird T.D., Gibson G.E., et al. Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. American Journal of Pathology 2009, 175:1810-1816.
107. 2+ cross-talk. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2777-2782.
108. Langston J.W., Ballard P.A. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. New England Journal of Medicine 1983, 309:310.
109. Cicchetti F., Lapointe N., Roberge-Tremblay A., Saint-Pierre M., Jimenez L., et al. Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats. Neurobiology of Disease 2005, 20:360-371.
110. DiMauro S., Schon E.A. Mitochondrial disorders in the nervous system. Annual Review of Neuroscience 2008, 31:91-123.
111. Danzer K.M., Haasen D., Karow A.R., Moussaud S., Habeck M., et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. Journal of Neuroscience 2007, 27:9220-9232.
112. Lashuel H.A., Petre B.M., Wall J., Simon M., Nowak R.J., et al. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. Journal of Molecular Biology 2002, 322:1089-1102.
113. Furukawa K., Matsuzaki-Kobayashi M., Hasegawa T., Kikuchi A., Sugeno N., et al. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. Journal of Neurochemistry 2006, 97:1071-1077.
114. Parihar M.S., Parihar A., Fujita M., Hashimoto M., Ghafourifar P. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. International Journal of Biochemistry and Cell Biology 2009, 41:2015-2024.
115. 2+ signaling in human neuroblastoma (SH-SY5Y) cells. Journal of Neurochemistry 2009, 111:1192-1201.
116. Cali T., Ottolini D., Negro A., Brini M. Alpha-synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. Journal of Biological Chemistry 2012, 287:17914-17929.
117. Schmidt S., Linnartz B., Mendritzki S., Sczepan T., Lubbert M., et al. Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria. Human Molecular Genetics 2011, 20:1197-1211.
118. Esteves A.R., Arduino D.M., Swerdlow R.H., Oliveira C.R., Cardoso S.M. Dysfunctional mitochondria uphold calpain activation: contribution to Parkinson's disease pathology. Neurobiology of Disease 2010, 37:723-730.
119. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K., et al. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Reports 2004, 5:213-218.
120. 2+ homeostasis in the skeletal muscle of DJ-1 null mice. Neurobiology of Aging 2011, 32:125-132.
121. Guzman J.N., Sanchez-Padilla J., Chan C.S., Surmeier D.J. Robust pacemaking in substantia nigra dopaminergic neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2009, 29:11011-11019.
122. Guzman J.N., Sanchez-Padilla J., Wokosin D., Kondapalli J., Ilijic E., et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 2010, 468:696-700.
123. Marongiu R., Spencer B., Crews L., Adame A., Patrick C., et al. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. Journal of Neurochemistry 2009, 108:1561-1574.
124. Gandhi S., Wood-Kaczmar A., Yao Z., Plun-Favreau H., Deas E., et al. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Molecular Cell 2009, 33:627-638.
125. Heeman B., Van den Haute C., Aelvoet S.A., Valsecchi F., Rodenburg R.J., et al. Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance. Journal of Cell Science 2011, 124:1115-1125.
126. Akundi R.S., Huang Z., Eason J., Pandya J.D., Zhi L., et al. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in pink1-deficient mice. PLoS One 2011, 6:e16038.
127. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983. The Huntington's Disease Collaborative Research Group.
128. Giacomello M., Hudec R., Lopreiato R. Huntington's disease, calcium, and mitochondria. Biofactors 2011, 37:206-218.
129. Thayer S.A., Miller R.J. Regulation of the intracellular free calcium concentration in single rat dorsal root ganglion neurones in vitro. Journal of Physiology 1990, 425:85-115.
130. Zheng S., Clabough E.B., Sarkar S., Futter M., Rubinsztein D.C., et al. Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genetics 2010, 6:e1000838.
131. Graham R.K., Deng Y., Slow E.J., Haigh B., Bissada N., et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 2006, 125:1179-1191.
132. Williams A.J., Paulson H.L. Polyglutamine neurodegeneration: protein misfolding revisited. Trends in Neurosciences 2008, 31:521-528.
133. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277:1990-1993.
134. Martindale D., Hackam A., Wieczorek A., Ellerby L., Wellington C., et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genetics 1998, 18:150-154.
135. Choo Y.S., Johnson G.V., MacDonald M., Detloff P.J., Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Human Molecular Genetics 2004, 13:1407-1420.
136. 2+ in transgenic Huntington disease rats. Journal of Biological Chemistry 2008, 283:30715-30724.
137. Milakovic T., Quintanilla R.A., Johnson G.V. Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. Journal of Biological Chemistry 2006, 281:34785-34795.
138. 2+ in R6/2 mice. Annals of Neurology 2006, 59:407-411.
139. Brustovetsky N., LaFrance R., Purl K.J., Brustovetsky T., Keene C.D., et al. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's disease. Journal of Neurochemistry 2005, 93:1361-1370.
140. Oliveira J.M., Jekabsons M.B., Chen S., Lin A., Rego A.C., et al. Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. Journal of Neurochemistry 2007, 101:241-249.
141. Perry G.M., Tallaksen-Greene S., Kumar A., Heng M.Y., Kneynsberg A., et al. Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease. Human Molecular Genetics 2010, 19:3354-3371.
142. Kaltenbach L.S., Romero E., Becklin R.R., Chettier R., Bell R., et al. Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genetics 2007, 3:e82.
143. Tang T.S., Tu H., Chan E.Y., Maximov A., Wang Z., et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 2003, 39:227-239.
144. 2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Neurobiology of Disease 2008, 31:80-88.
145. Costa V., Giacomello M., Hudec R., Lopreiato R., Ermak G., et al. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. EMBO Molecular Medicine 2010, 2:490-503.
146. Duffy L.M., Chapman A.L., Shaw P.J., Grierson A.J. Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology 2011, 37:336-352.
147. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nature Reviews Neuroscience 2006, 7:710-723.
148. Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14:1105-1116.
149. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 2006, 351:602-611.
150. Dion P.A., Daoud H., Rouleau G.A. Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nature Reviews Genetics 2009, 10:769-782.
151. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
152. 2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends in Neurosciences 2005, 28:494-500.
153. Ikonomidou C., Qin Qin Y., Labruyere J., Olney J.W. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology 1996, 55:211-224.
154. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:6591-6595.
155. Carriedo S.G., Sensi S.L., Yin H.Z., Weiss J.H. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro. Journal of Neuroscience 2000, 20:240-250.
156. Van Damme P., Van Den Bosch L., Van Houtte E., Callewaert G., Robberecht W. GluR2-dependent properties of AMPA receptors determine the selective vulnerability of motor neurons to excitotoxicity. Journal of Neurophysiology 2002, 88:1279-1287.
157. Heath P.R., Tomkins J., Ince P.G., Shaw P.J. Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. Neuroreport 2002, 13:1753-1757.
158. Kawahara Y., Kwak S., Sun H., Ito K., Hashida H., et al. Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for excitotoxicity in ALS. Journal of Neurochemistry 2003, 85:680-689.
159. Kawahara Y., Ito K., Sun H., Aizawa H., Kanazawa I., et al. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004, 427:801.
160. Van Damme P., Braeken D., Callewaert G., Robberecht W., Van Den Bosch L. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis. Journal of Neuropathology and Experimental Neurology 2005, 64:605-612.
161. Tateno M., Sadakata H., Tanaka M., Itohara S., Shin R.M., et al. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. Human Molecular Genetics 2004, 13:2183-2196.
162. Spalloni A., Albo F., Ferrari F., Mercuri N., Bernardi G., et al. Cu/Zn-superoxide dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiology of Disease 2004, 15:340-350.
163. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Annals of Neurology 1995, 38:73-84.
164. Rothstein J.D., Martin L.J., Kuncl R.W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New England Journal of Medicine 1992, 326:1464-1468.
165. Tovar Y.R.L.B., Santa-Cruz L.D., Zepeda A., Tapia R. Chronic elevation of extracellular glutamate due to transport blockade is innocuous for spinal motoneurons in vivo. Neurochemistry International 2009, 54:186-191.
166. Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 2010, 47:165-174.
167. Bianchi K., Rimessi A., Prandini A., Szabadkai G., Rizzuto R. Calcium and mitochondria: mechanisms and functions of a troubled relationship. Biochimica et Biophysica Acta 2004, 1742:119-131.
168. Appel B., Givan L.A., Eisen J.S. Delta-Notch signaling and lateral inhibition in zebrafish spinal cord development. BMC Developmental Biology 2001, 1:13.
169. Fahandejsaadi A., Leung E., Rahaii R., Bu J., Geula C. Calbindin-D28K, parvalbumin and calretinin in primate lower motor neurons. Neuroreport 2004, 15:443-448.
170. David G. Mitochondrial clearance of cytosolic Ca(2+) in stimulated lizard motor nerve terminals proceeds without progressive elevation of mitochondrial matrix [Ca(2+)]. Journal of Neuroscience 1999, 19:7495-7506.
171. 2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Letters 1997, 414:365-368.
172. Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., et al. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Experimental Neurology 2009, 218:333-346.
173. Kirkinezos I.G., Hernandez D., Bradley W.G., Moraes C.T. An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment. Journal of Neurochemistry 2004, 88:821-826.
174. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. American Journal of Human Genetics 2004, 75:822-831.
175. De Vos K.J., Morotz G.M., Stoica R., Tudor E.L., Lau K.F., et al. VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Human Molecular Genetics 2012, 21:1299-12311.
176. 2+-dependent ER-associated pathway. Journal of Neurochemistry 2010, 114:795-809.
177. Morotz G.M., De Vos K.J., Vagnoni A., Ackerley S., Shaw C.E., et al. Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Human Molecular Genetics 2012, 21:1979-1988.